EGFR and non-small cell lung carcinoma: We also analysed recently published data of the site of recurrence of 481 resected non-small cell lung cancers according to KRAS and EGFR mutation status, and found that KRAS mutations overall were highly significantly (P<0.0001; Fischer's exact test) associated with pleural recurrence (Table 4).